Evaluation Effectiveness and Safety of (cTACE or DEB-TACE + FOLFOX Regimen HAIC) Combined With Camrelizumab and Apatinib Mesylas in the Treatment of Advanced Hepatocellular Carcinoma
PHASE2
This study used (cTACE or DEB-TACE + FOLFOX scheme HAIC) combined with PD-1...
A Study on the Heterogeneity of Efficacy of Interventional Therapy Combined With Systemic Therapy for Liver Cancer Based on Multi-center Real-world Data
N/A
The system assesses the heterogeneity of HCC patients in terms of therapeut...
Status
Not Yet Recruiting
Location
The Second Affiliated Hospital of Hainan Medical Universsity
A Phase III Randomized Study of TACE Plus an Oral Triple-Agent Cocktail Versus TACE Plus First-Line Targeted Immunotherapy in Unresectable Hepatocellular Carcinoma
PHASE2
This is a prospective, multicenter, randomized, open-label phase 3 study ev...